Anaptysbio (ANAB) Return on Equity [ROE] (2017 - 2026)
Anaptysbio (ANAB) reported Return on Equity [ROE] of -107.24% for Q1 2026, up 160.90 percentage points from -268.14% a year earlier and up 232.30 percentage points from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Return on Equity [ROE] (2017 - 2026) Analysis & Trends
For FY2025, Anaptysbio posted Return on Equity [ROE] of -24.49%, up 158.23 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of -19.51 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -182.71% in FY2024 (-89.27 pp), -93.44% in FY2023 (-51.82 pp), -41.62% in FY2022 (-26.27 pp) and -15.35% in FY2021 (-10.38 pp).
- The Q1 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q3 2023.
- Year over year, Return on Equity [ROE] gained in 1 of the last six quarters, with an average year-over-year change of -135.93 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2026 (a gain of 160.90 percentage points); the low point was Q2 2024 (a drop of 513.95 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Anaptysbio | 1.41 Bn | 296.12 Mn | - | -107.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -107.24% |
| Dec 31, 2025 | -339.54% |
| Mar 31, 2025 | -268.14% |
| Dec 31, 2024 | -187.11% |
| Sep 30, 2024 | -351.54% |
| Jun 30, 2024 | -590.09% |
| Mar 31, 2024 | -240.36% |
| Dec 31, 2023 | -152.80% |
| Sep 30, 2023 | -103.56% |
| Jun 30, 2023 | -76.14% |
| Mar 31, 2023 | -51.24% |
| Dec 31, 2022 | -39.87% |
| Sep 30, 2022 | -40.06% |
| Jun 30, 2022 | -30.20% |
| Mar 31, 2022 | -20.26% |
| Dec 31, 2021 | -15.24% |
| Sep 30, 2021 | 2.17% |
| Jun 30, 2021 | -2.27% |
| Mar 31, 2021 | -7.66% |
| Dec 31, 2020 | -5.27% |
API Access
Anaptysbio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();